Skip to main content

Participate

Available Research Studies

New Treatment Studies

Study 1: Brief Description of the Biomarker and Safety Study of Clozapine for Patients with Benign Ethnic Neutropenia (Ben)

  • 18-64 years old
  • African-American or history of low white blood cell count
  • Eligible for clozapine treatment
  • No major health problems
  • Compensation provided
  • Find out more information

Matt Glassman M.S.
410-402-6411
mglassman@som.umaryland.edu

Study 2: Confirmatory Double-Blind Placebo-Controlled Efficacy Trial of a Gluten Free Diet in a subgroup of Persons with Schizophrenia who have high levels of IgG Anti-Gliadin Antibodies (AGA IG)

We are conducting a 2-phase study. The first phase is getting tested for antibodies to gluten and the second is an opportunity to participate in a clinical trial if you test positive for the blood test antibody.

  • 18-64 years old
  • Diagnosis of schizophrenia or schizoaffective disorder
  • Blood test determines a positive antibody test for AGA IgG
  • Find out more information

Megan Powell
410-402-6413
mmpowell@som.umaryland.edu

Study 3: Ashwagandha for the Treatment of Schizophrenia

  • 18-64 years old
  • Diagnosis of schizophrenia or schizoaffective disorder
  • Currently taking antipsychotic
  • Cannot be pregnant
  • Cannot be addicted to drugs or alcohol
  • No major health problems
  • Compensation Provided
  • Find out more information

Chris Brown
410-402-7878
Cbbrown@som.umaryland.edu

Study 4: Pharmacogenetic Treatment with Anti-Glutaminergic Agents for Comorbid PTSD & AUD

  • 18-65 years old
  • African-American
  • Regular heavy drinking
  • Experienced a traumatic event
  • No major health problems
  • Compensation provided
  • Find out more information

Shelby Goodwin
410-402-6412
rethinkyourdrinking@som.umaryland.edu

Brain Imaging Studies

Study 1: Social Processes in the Brain (SPINS)

  • Age 18-55
  • Population: Schizophrenia or a related disorder
  • **Healthy participants who have no mental illness are also needed for this study
  • Compensation provided
  • Find out more information

Christine Brown, BA
410-402-7878
cbbrown@som.umaryland.edu

Study 2: Tryptophan Magnetic Resonance Imaging (MRI) in People with Schizophrenia and Healthy Controls  

Study involves ingestion of the dietary supplement, tryptophan; blood draws; cognitive testing; and a 90-minute magnetic resonance imaging (MRI) scan of the brain,. Compensation is provided.

  • 18-55 Years Old
  • People with a diagnosis of Schizophrenia, Schizoaffective Disorder or Schizophreniform Disorder, or Healthy Controls
  • Female participants must agree to use a medically accepted means of contraception
  • Find out more information

Sam Kane-Gerard, BA
410-402-6120
SGerard@som.umaryland.edu

Study 3:

  • Age 18-62
  • Population: Schizophrenia, Schizoaffective
  • **Healthy participants who have no mental illness are also needed for these studies
  • Compensation provided

Caroline Silva
410-402-6126
csilva@som.umaryland.edu

Cognitive Studies

Study 1: Attention and Working Memory

  • Age 18-55
  • Good physical health
  • Diagnosis: Schizophrenia, Schizoaffective
  • **Healthy participants who have no mental illness are also needed for these studies
  • Compensation provided
  • Find out more information

Sharon August, MA
410-402-6057
saugust@som.umaryland.edu

Study 2: Development of Computational Modeling to Identify Symptom Changes in Schizophrenia and Depression

We are recruiting healthy controls, people with schizophrenia or depression for this study

  • People with Schizophrenia and Schizophrenia Related Disorders and Healthy Controls.
  • Age 18-64
  • Have a valid Facebook and/or Twitter account.
  • Find out more information

Anne Werkheiser
410-402-6874
Awerkeiser@som.umaryland.edu

Smoking Studies

  • Age 18-62
  • Population: Current smokers
  • **Healthy participants who have no mental illness are needed for these studies
  • Compensation provided
  • Find out more information

Caroline Silva
410-402-6126
csilva@som.umaryland.edu

Blood Draw Studies

Study 1: The effects of Clozapine on DNA methylation in Peripheral Blood in People with Schizophrenia

We are recruiting both healthy controls and people with schizophrenia for this study and have groups we are recruiting.

  • 18-69 Years Old
  • Diagnosis of Schizophrenia or Healthy Control
  • History of treatment with clozapine or other antipsychotic if you have a diagnosis of Schizophrenia
  • Find out more information

Sam Kane-Gerard
410-402-6120
SGerard@som.umaryland.edu 

Give to Center


Join a Study


Videos

MPRC Director, Dr. Robert W. Buchanan, provides an overview of the center.


Deanna L. Kelly wins the 2017 Maltz Prize for Innovative & Promising Research from the Brain and Behavior Research Foundation



Events:

View All Events »